Global biotherapeutics
company CSL has announced that
its influenza vaccines business
will now operate under the brand
Seqirus effective today, following
the merger of the recently-acquired
Novartis influenza business
and its existing vaccines and
pharmaceutical business bioCSL.
The Seqirus brand, which the
company says derives from the
phrase “securing health for all of
us,” includes a new logo and visual
identity.The above article was sent to subscribers in Pharmacy Daily's issue from 10 Nov 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Nov 15
RESEARCHERS at Charles Darwin University (CDU) are advancing a novel drug delivery system that could potentially eliminate the need for injections to treat various chronic diseases.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.